PubMed

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Hayden MR, Tyagi SC.

Nutr Metab (Lond). 2004 Oct 19;1(1):10.PMID: 15507132 [PubMed - as supplied by publisher]Related articlesFree article

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.

Hayden MR, Tyagi SC.

Cardiovasc Diabetol. 2003 Feb 12;2:2.PMID: 12628022 [PubMed]Related articlesFree article

Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation.

Hayden MR, Tyagi SC.

Cardiovasc Diabetol. 2004 Feb 4;3:1.PMID: 14761253 [PubMed]Related articlesFree article

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation.

Hayden MR, Tyagi SC.

Nutr J. 2004 May 10;3:4.PMID: 15134582 [PubMed]Related articlesFree article

Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.

Hayden MR, Tyagi SC.

Cardiovasc Diabetol. 2002 Sep 27;1:3.PMID: 12392600 [PubMed]Related articlesFree article

Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Woodman RJ, Chew GT, Watts GF.

Drugs. 2005;65(1):31-74. Review.PMID: 15610050 [PubMed - indexed for MEDLINE]Related articles

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.PMID: 18669160 [PubMed - indexed for MEDLINE]Related articles

The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins.

Hamed SA, Nabeshima T.

J Pharmacol Sci. 2005 Aug;98(4):340-53. Epub 2005 Aug 2. Review.PMID: 16079465 [PubMed - indexed for MEDLINE]Related articlesFree article

Uric acid and oxidative stress: relative impact on cardiovascular risk?

Strazzullo P, Puig JG.

Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):409-14. Review.PMID: 17643880 [PubMed - indexed for MEDLINE]Related articles

Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R.

Cardiovasc Diabetol. 2005 Mar 18;4(1):4. Review.PMID: 15777477 [PubMed - indexed for MEDLINE]Related articlesFree article

Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy.

Hayden MR, Tyagi SC.

Med Sci Monit. 2004 Dec;10(12):RA291-307. Review.PMID: 15567993 [PubMed - indexed for MEDLINE]Related articles

Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.

Sautin YY, Nakagawa T, Zharikov S, Johnson RJ.

Am J Physiol Cell Physiol. 2007 Aug;293(2):C584-96. Epub 2007 Apr 11.PMID: 17428837 [PubMed - indexed for MEDLINE]Related articlesFree article

Uric acid and hypertension.

Schachter M.

Curr Pharm Des. 2005;11(32):4139-43. Review.PMID: 16375735 [PubMed - indexed for MEDLINE]Related articles

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.PMID: 17420118 [PubMed - indexed for MEDLINE]Related articles

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.

Linnemann B, Voigt W, Nobel W, Janka HU.

Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):127-34.PMID: 16636979 [PubMed - indexed for MEDLINE]Related articles

Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.

Hayden MR, Whaley-Connell A, Sowers JR.

Am J Nephrol. 2005 Nov-Dec;25(6):553-69. Review.PMID: 16210838 [PubMed - indexed for MEDLINE]Related articles

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

Oxidative stress, endothelial dysfunction and cerebrovascular disease.

Zalba G, Fortuño A, San José G, Moreno MU, Beloqui O, Díez J.

Cerebrovasc Dis. 2007;24 Suppl 1:24-9. Epub 2007 Nov 1. Review.PMID: 17971636 [PubMed - indexed for MEDLINE]Related articles

Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.

Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.

Eur J Pharmacol. 2005 Mar 21;511(1):53-64.PMID: 15777779 [PubMed - indexed for MEDLINE]Related articles